Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.

Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, Zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H

Research article (journal) | Peer reviewed

Details about the publication

JournalBlood (Blood)
Volume116
Page range3564-3571
StatusPublished
Release year2010
Language in which the publication is writtenEnglish
DOI10.1182/blood-2009-09-240978

Authors from the University of Münster

Berdel, Wolfgang Eduard
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Dugas, Martin
Institute of Medical Informatics
Hascher, Antje
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Koschmieder, Steffen
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Müller-Tidow, Carsten
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Schlenke, Peter
Institute of Transfusion Medicine
Schmitz, Wilhelm
Institute of Pharmacology and Toxicology
Seidl, Markus
Institute of Biochemistry
Tickenbrock, Lara
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Tschanter, Petra
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)